These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7103460)

  • 41. Enantiomer-enantiomer interaction of a uricosuric antihypertensive diuretic (DBCA) in renal tubular secretion and stereoselective inhibition by probenecid in the cynomolgus monkey.
    Nakano M; Higaki K; Kawahara S
    Xenobiotica; 1993 May; 23(5):525-36. PubMed ID: 8342300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.
    Nadai M; Apichartpichean R; Hasegawa T; Nabeshima T
    J Pharm Sci; 1992 Oct; 81(10):1024-7. PubMed ID: 1432614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.
    Hedaya MA; Sawchuk RJ
    J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of probenecid on the pharmacokinetics of cefotaxime in sheep.
    Guerrini VH; Filippich LJ; English PB; Cao GR; Bourne DW
    J Vet Pharmacol Ther; 1985 Mar; 8(1):38-46. PubMed ID: 3989899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections.
    Hintz M; Connor JD; Spector SA; Blum MR; Keeney RE; Yeager AS
    Am J Med; 1982 Jul; 73(1A):210-4. PubMed ID: 6285713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of probenecid on the renal elimination of cimetidine.
    Gisclon LG; Boyd RA; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Apr; 45(4):444-52. PubMed ID: 2702802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
    Shah GM; Winer RL; Krasny HC
    Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers.
    Inotsume N; Nishimura M; Nakano M; Fujiyama S; Sato T
    J Clin Pharmacol; 1990 Jan; 30(1):50-6. PubMed ID: 2303581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of "true" creatinine clearance in rats reveals extensive renal secretion.
    Darling IM; Morris ME
    Pharm Res; 1991 Oct; 8(10):1318-22. PubMed ID: 1796052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A physiologically based kidney model for the renal clearance of ranitidine and the interaction with cimetidine and probenecid in the dog.
    Boom SP; Meyer I; Wouterse AC; Russel FG
    Biopharm Drug Dispos; 1998 Apr; 19(3):199-208. PubMed ID: 9570004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Mikus G; Walter-Sack I; Haefeli WE
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):431-7. PubMed ID: 17725176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acyclovir concentrations and tolerance during repetitive administration for 18 days.
    Laskin OL; Saral R; Burns WH; Angelopulos CM; Lietman PS
    Am J Med; 1982 Jul; 73(1A):221-4. PubMed ID: 7048913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of imipenem in healthy volunteers.
    Norrby SR; Björnegård B; Ferber F; Jones KH
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():109-24. PubMed ID: 6583194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal handling of captopril: effect of probenecid.
    Sinhvi SM; Duchin KL; Willard DA; McKinstry DN; Migdalof BH
    Clin Pharmacol Ther; 1982 Aug; 32(2):182-9. PubMed ID: 7047044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacokinetics of ceftizoxime with and without probenecid].
    Adam D; Timmler R
    Arzneimittelforschung; 1982; 32(4):416-9. PubMed ID: 6285937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients.
    Massarella JW; Nazareno LA; Passe S; Min B
    Pharm Res; 1996 Mar; 13(3):449-52. PubMed ID: 8692740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.